Invesco
PLRX icon

Invesco’s Pliant Therapeutics PLRX Stock Holding History

Invesco’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$145K Buy
115,218
+1,284
+1% +$1.62K ﹤0.01% 3569
2025
Q4 		$139K Buy
113,934
+6,838
+6% +$10.3K ﹤0.01% 3602
2025
Q3 		$159K Buy
107,096
+33,602
+46% +$51.3K ﹤0.01% 3610
2025
Q2 		$85.3K Buy
73,494
+4,531
+7% +$6.4K ﹤0.01% 3669
2025
Q1 		$93.1K Buy
68,963
+20,449
+42% +$124K ﹤0.01% 3635
2024
Q4 		$639K Buy
48,514
+2,182
+5% +$29.8K ﹤0.01% 3130
2024
Q3 		$519K Sell
46,332
-823
-2% -$10.3K ﹤0.01% 3223
2024
Q2 		$507K Sell
47,155
-627
-1% -$8.08K ﹤0.01% 3261
2024
Q1 		$712K Buy
47,782
+20,258
+74% +$334K ﹤0.01% 3163
2023
Q4 		$498K Sell
27,524
-11,451
-29% -$174K ﹤0.01% 3222
2023
Q3 		$676K Buy
38,975
+7,981
+26% +$138K ﹤0.01% 3052
2023
Q2 		$562K Buy
+30,994
New +$734K ﹤0.01% 3179
2022
Q4 		– Sell
-272,667
Closed -$5.7M – 4053
2022
Q3 		$5.7M Buy
+272,667
New +$5.22M ﹤0.01% 2153
2022
Q2 		– Sell
-10,200
Closed -$72K – 4119
2022
Q1 		$72K Buy
10,200
+189
+2% +$1.93K ﹤0.01% 3896
2021
Q4 		$134K Sell
10,011
-1,190
-11% -$18.9K ﹤0.01% 3858
2021
Q3 		$189K Buy
11,201
+1,698
+18% +$36K ﹤0.01% 3818
2021
Q2 		$276K Buy
+9,503
New +$296K ﹤0.01% 3663

Other funds holding PLRX

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Invesco's PLRX Position: Q1 2026 in Review

Invesco increased its Pliant Therapeutics (PLRX) stake by 1.1% in Q1 2026, buying an estimated $1.62K and bringing the position to 115,218 shares worth $145K. The position accounts for ﹤0.01% of the portfolio, ranked #3569.

Invesco first reported a position in PLRX in Q2 2021 and has held it in 17 quarters since. The position peaked at $5.7M in Q3 2022. 91 funds tracked by Wall St. Rank hold PLRX as of Q1 2026.

  • Invesco held 115,218 shares of Pliant Therapeutics worth $145K as of Q1 2026.
  • Invesco bought 1,284 Pliant Therapeutics shares in Q1 2026, an estimated $1.62K.
  • Pliant Therapeutics made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #3569 holding.
  • Invesco first reported a position in Pliant Therapeutics in Q2 2021 and has held it in 17 quarters since.
  • Invesco's Pliant Therapeutics position peaked at $5.7M in Q3 2022.
  • 91 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.